Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Double-blind Study of Testosterone Replacement Therapy or Placebo in Testicular Cancer Survivors With Mild Leydig Cell Insufficiency (Einstein-intervention)

NCT02991209 is registered in ClinicalTrials.gov with Mikkel Bandak as lead sponsor.

NCT NCT02991209
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02991209 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Double-blind Study of Testosterone Replacement Therapy or Placebo in Testicular Cancer Survivors With Mild Leydig Cell Insufficiency (Einstein-intervention)
Lead sponsor
Mikkel Bandak
Phase
Phase 2/3
Overall status
Completed
Start date
November 30, 2016
Completion date
June 30, 2019
Enrollment
69 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leydig cell failure in adult, metabolic syndrome, testicular cancer